The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Regenerative Medicine Market Research Report 2024
Synopsis
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
Global Veterinary Regenerative Medicine market is projected to reach US$ 612.9 million in 2029, increasing from US$ 266 million in 2022, with the CAGR of 12.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Regenerative Medicine market research.
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Regenerative Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis
Segment by Type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Veterinary Regenerative Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
Global Veterinary Regenerative Medicine market is projected to reach US$ 612.9 million in 2029, increasing from US$ 266 million in 2022, with the CAGR of 12.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Regenerative Medicine market research.
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Regenerative Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis
Segment by Type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Veterinary Regenerative Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Regenerative Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Platelet-Rich Plasma (PRP)
1.2.3 Stem Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Regenerative Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals/Clinics
1.3.3 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Regenerative Medicine Market Perspective (2018-2029)
2.2 Veterinary Regenerative Medicine Growth Trends by Region
2.2.1 Global Veterinary Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary Regenerative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Regenerative Medicine Forecasted Market Size by Region (2024-2029)
2.3 Veterinary Regenerative Medicine Market Dynamics
2.3.1 Veterinary Regenerative Medicine Industry Trends
2.3.2 Veterinary Regenerative Medicine Market Drivers
2.3.3 Veterinary Regenerative Medicine Market Challenges
2.3.4 Veterinary Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Regenerative Medicine Players by Revenue
3.1.1 Global Top Veterinary Regenerative Medicine Players by Revenue (2018-2023)
3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Regenerative Medicine Revenue
3.4 Global Veterinary Regenerative Medicine Market Concentration Ratio
3.4.1 Global Veterinary Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Regenerative Medicine Revenue in 2022
3.5 Veterinary Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Veterinary Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Veterinary Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Regenerative Medicine Breakdown Data by Type
4.1 Global Veterinary Regenerative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2024-2029)
5 Veterinary Regenerative Medicine Breakdown Data by Application
5.1 Global Veterinary Regenerative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Veterinary Regenerative Medicine Market Size (2018-2029)
6.2 North America Veterinary Regenerative Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary Regenerative Medicine Market Size by Country (2018-2023)
6.4 North America Veterinary Regenerative Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Regenerative Medicine Market Size (2018-2029)
7.2 Europe Veterinary Regenerative Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary Regenerative Medicine Market Size by Country (2018-2023)
7.4 Europe Veterinary Regenerative Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Regenerative Medicine Market Size (2018-2029)
8.2 Asia-Pacific Veterinary Regenerative Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Regenerative Medicine Market Size (2018-2029)
9.2 Latin America Veterinary Regenerative Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary Regenerative Medicine Market Size by Country (2018-2023)
9.4 Latin America Veterinary Regenerative Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Regenerative Medicine Market Size (2018-2029)
10.2 Middle East & Africa Veterinary Regenerative Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACell Inc. (Integra LifeSciences)
11.1.1 ACell Inc. (Integra LifeSciences) Company Detail
11.1.2 ACell Inc. (Integra LifeSciences) Business Overview
11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Introduction
11.1.4 ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.1.5 ACell Inc. (Integra LifeSciences) Recent Development
11.2 Animal Cell Therapies, Inc.
11.2.1 Animal Cell Therapies, Inc. Company Detail
11.2.2 Animal Cell Therapies, Inc. Business Overview
11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Introduction
11.2.4 Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.2.5 Animal Cell Therapies, Inc. Recent Development
11.3 Ardent
11.3.1 Ardent Company Detail
11.3.2 Ardent Business Overview
11.3.3 Ardent Veterinary Regenerative Medicine Introduction
11.3.4 Ardent Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.3.5 Ardent Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Detail
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Cell Therapy Sciences
11.5.1 Cell Therapy Sciences Company Detail
11.5.2 Cell Therapy Sciences Business Overview
11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Introduction
11.5.4 Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.5.5 Cell Therapy Sciences Recent Development
11.6 Dechra
11.6.1 Dechra Company Detail
11.6.2 Dechra Business Overview
11.6.3 Dechra Veterinary Regenerative Medicine Introduction
11.6.4 Dechra Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.6.5 Dechra Recent Development
11.7 Enso Discoveries
11.7.1 Enso Discoveries Company Detail
11.7.2 Enso Discoveries Business Overview
11.7.3 Enso Discoveries Veterinary Regenerative Medicine Introduction
11.7.4 Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.7.5 Enso Discoveries Recent Development
11.8 South Paws Veterinary Surgical Specialists
11.8.1 South Paws Veterinary Surgical Specialists Company Detail
11.8.2 South Paws Veterinary Surgical Specialists Business Overview
11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Introduction
11.8.4 South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.8.5 South Paws Veterinary Surgical Specialists Recent Development
11.9 Veterinary Specialty Center
11.9.1 Veterinary Specialty Center Company Detail
11.9.2 Veterinary Specialty Center Business Overview
11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Introduction
11.9.4 Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.9.5 Veterinary Specialty Center Recent Development
11.10 Vetbiologics
11.10.1 Vetbiologics Company Detail
11.10.2 Vetbiologics Business Overview
11.10.3 Vetbiologics Veterinary Regenerative Medicine Introduction
11.10.4 Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.10.5 Vetbiologics Recent Development
11.11 Vetherapy
11.11.1 Vetherapy Company Detail
11.11.2 Vetherapy Business Overview
11.11.3 Vetherapy Veterinary Regenerative Medicine Introduction
11.11.4 Vetherapy Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.11.5 Vetherapy Recent Development
11.12 VetStem, Inc.
11.12.1 VetStem, Inc. Company Detail
11.12.2 VetStem, Inc. Business Overview
11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Introduction
11.12.4 VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.12.5 VetStem, Inc. Recent Development
11.13 Zoetis
11.13.1 Zoetis Company Detail
11.13.2 Zoetis Business Overview
11.13.3 Zoetis Veterinary Regenerative Medicine Introduction
11.13.4 Zoetis Revenue in Veterinary Regenerative Medicine Business (2018-2023)
11.13.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
